FDA approves CAR T-cell therapy, a state-of-the-art immune-therapy trial to target childhood leukemia. Mott is the only certified treatment center in Michigan and one of a select few in the country to offer it.
Hospitals & Centers
A new study uncovers changes in the makeup of the cardiac intensive care unit as more patients are primarily diagnosed with noncardiac conditions.
An analysis of Medicare Part D data reveals that a preference among eye care providers for name-brand medication has systemwide cost implications.
Ophthalmologists urge providers to stop prescribing antibiotics for a common eye condition that typically clears up without medication.
Even in low amounts, interruptions to parent-child time caused by digital technology are associated with greater child behavior problems, a new study suggests.
The Magnet Recognition Program® isn’t a prize or an award. It’s a performance-driven recognition credential.